跳至主要内容
临床试验/ITMCTR2000003095
ITMCTR2000003095招募中1 期

Acupuncture based on specific acupoint theory for the reduction of atrial fibrillation burden: a randomized controlled pilot trial

Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. Persistent AF lasting no more than 3 years;
  • 2. Age between 18 and 75 years old (male or female);
  • 3. No acupuncture treatment within the previous 6 months.

排除标准

  • 1. Severe heart failure (New York Heart Association(NYHA)class III or IV);
  • 2. Echocardiographic parameters: left ventricular ejection fraction < 40%, left atrium diameter > 5.0cm;
  • 3. Severe lung, liver, kidney disease or other serious primary diseases;
  • 4. Skin allergy to ECG monitoring electrode patch.
  • 5. The estimated life expectancy of < 1 year.

研究者

发起方
Beijing University of Chinese Medicine

相似试验